Skip to content
Trial Eligibility
Menu

Lung Cancer Clinical Trials near Dallas, TX

110 studies for Lung Cancer are recruiting at 201 sites within 50 miles of Dallas, Texas, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Lung Cancer trials in the US or all trials near Dallas.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Lung Cancer studies enrolling near Dallas

Showing the 50 nearest of 110 studies.
  1. A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

    NCT07144280

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Texas Oncology - DFW (Dallas, TX); Texas Oncology - DFW (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    23 sites within 50 mi
  2. Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

    NCT07222566

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Texas Oncology - DFW (Dallas, TX); Texas Oncology - DFW (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    19 sites within 50 mi
  3. Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

    NCT07226999

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Texas Oncology - DFW (Dallas, TX); Texas Oncology - DFW (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    19 sites within 50 mi
  4. A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

    NCT05208762

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: UT Southwestern Medical Center - Redbird (Dallas, TX); Univ. of TX Southwestern Medical Center - Zale Lipshy University Hospital (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  5. Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

    NCT05176483

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Exelixis Clinical Site #89 (Dallas, TX); Exelixis Clinical Site #73 (Irving, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  6. Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

    NCT06096844

    • Phase 3
    • Ages 70 years and older
    • Sex: All

    Nearest sites: Parkland Memorial Hospital (Dallas, TX); UT Southwestern/Simmons Cancer Center-Dallas (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  7. LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

    NCT06216301

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Old Parkland Hospital Hematology Oncology Clinic (Dallas, TX); UT Southwestern Medical Center (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  8. A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

    NCT06667076

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Parkland Health and Hospital System (Dallas, TX); Texas Oncology DFW (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  9. Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

    NCT04267848

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Parkland Memorial Hospital (Dallas, TX); UT Southwestern/Simmons Cancer Center-Dallas (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  10. The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

    NCT04585750

    • Phase 1/2
    • Ages 12 years and older
    • Sex: All

    Nearest sites: UT Southwest Simmons Cancer Center (Dallas, TX); Texas Oncology (Bedford, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  11. Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

    NCT05245500

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Ut Southwestern (Dallas, TX); Texas Oncology - DFW (Fort Worth, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  12. Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

    NCT05579366

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Mary Crowley Cancer Research (Dallas, TX); USOR Texas Oncology (Fort Worth, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  13. A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

    NCT06095505

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Texas Oncology-Baylor Charles A. Sammons Cancer Center (Dallas, TX); University of Texas Southwestern Medical Center (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  14. A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

    NCT06623422

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Texas Oncology - DFW ( Site 8103) (Dallas, TX); UT Southwestern Medical Center ( Site 0190) (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  15. Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

    NCT06625775

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: SCRI at Mary Crowley (Dallas, TX); University of Texas Southwestern Medical Center (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  16. Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

    NCT06767514

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Clinical Study Site (Dallas, TX); Clinical Study Site (Fort Worth, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  17. A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

    NCT06778863

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Baylor University Medical Center (Dallas, TX); Mary Crowley Cancer Research (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  18. A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

    NCT06793215

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: The University of Texas Southwestern Medical Center at Dallas (Dallas, TX); JPS Health Network (Fort Worth, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  19. Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

    NCT07080242

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: NEXT Dallas (Dallas, TX); START Dallas- Fort Worth (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  20. A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

    NCT07540572

    • Phase 1
    • Ages 18 to 99 years
    • Sex: All

    Nearest sites: NEXT Texas LLC - Dallas (Dallas, TX); START Dallas Fort Worth, LLC (Fort Worth, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  21. Metabolic Biomarkers in Thoracic Cancers

    NCT02095808

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Texas Southwestern Medical Center (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

    NCT02468024

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Texas Southwestern Medical Center (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  23. A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

    NCT03093116

    • Phase 1/2
    • Ages 12 years and older
    • Sex: All

    Nearest site: UT Southwestern Medical Center (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  24. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    NCT03452774

    • Observational
    • Ages Any age
    • Sex: All

    Nearest site: Massive Bio SYNERGY-AI site (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

    NCT03526835

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Texas Oncology (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  26. Multiparametric Image Analysis and Correlation With Outcomes in Lung Cancer Screening and Early Stage Lung Cancer

    NCT03563976

    • Observational
    • Ages 18 to 99 years
    • Sex: All

    Nearest site: UT Southwestern Medical Center (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  27. Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

    NCT04181060

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: UT Southwestern/Simmons Cancer Center-Dallas (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  28. A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

    NCT04370587

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Mary Crowley Cancer Research (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  29. Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

    NCT04613596

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Texas Oncology - Dallas Fort Worth (DFW) - Baylor Charles A. Sammons Cancer Center (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  30. Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

    NCT04777994

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Texas Southwestern Medical Center /ID# 251974 (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  31. ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

    NCT05059444

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: UT Southwestern Medical Center (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  32. Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

    NCT05379985

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Mary Crowley Cancer Research (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  33. A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma

    NCT05456256

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: UT Southwestern Medical Center (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  34. JAB-2485 Activity in Adult Patients With Advanced Solid Tumors

    NCT05490472

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Mary Crowley Cancer Research (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  35. Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients

    NCT05703971

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Texas Oncology - DFW (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  36. Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments, Using Multiomics

    NCT05736029

    • Observational
    • Ages 18 years and older
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Baylor Scott and White Research Institute (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  37. A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

    NCT05914116

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Research Site 120 (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  38. A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

    NCT05941507

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Mary Crowley Cancer Research (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  39. A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

    NCT05948865

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: NEXT Dallas (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  40. KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

    NCT06026410

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: UT Southwestern Simmons Cancer Center (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  41. Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

    NCT06040541

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Sarah Cannon Research Institute at Mary Crowley (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  42. Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

    NCT06047379

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Baylor, Scott and White Research Institute (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  43. Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

    NCT06218914

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Research Site (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  44. A Phase 1/1b Study of IAM1363 in HER2 Cancers

    NCT06253871

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Mary Crowley Cancer Research (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  45. A Study of KK2269 in Adult Participants With Solid Tumors

    NCT06266299

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: The University of Texas Southwestern Medical Center (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  46. A Registry for People With Lung Cancer

    NCT06424327

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: Baylor University Medical Center (Data Collection Only) (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  47. A Study of VET3-TGI in Patients With Solid Tumors

    NCT06444815

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Mary Crowley Cancer Research (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  48. A Study of DM005 in Patients With Advanced Solid Tumors

    NCT06515990

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Sarah Cannon Research Institute at Mary Crowley (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  49. Study of XB010 in Subjects With Solid Tumors

    NCT06545331

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Baylor University Medical Center (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  50. A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

    NCT06568939

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Texas Oncology - Dallas - Worth Street /ID# 278947 (Dallas, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Lung Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.